• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Statistical considerations for preparation of a study protocol in pharmacological studies].

作者信息

Yamada M, Hashimoto T, Maeda H

机构信息

Ad Hoc Committee on Statistics, Japan Pharmaceutical Manufacturers Association, Tokyo, Japan.

出版信息

Nihon Yakurigaku Zasshi. 2000 Jul;116(1):18-22. doi: 10.1254/fpj.116.18.

DOI:10.1254/fpj.116.18
PMID:10976448
Abstract

In order to develop a new drug with scientific rationale, it is important to design a study properly. We suggested appropriate statistical considerations in the course of planning the study that are helpful for correct evaluation of the results of a pharmacological study, the information of which will be reflected in the planning of subsequent pharmacological and clinical studies. The statistical considerations for designing a pharmacological study are as follows: 1. clarification about the purpose of the study, 2. clear statement about the endpoint of the study, 3. framing of hypotheses, 4. selection of statistical analysis method, 5. statistical considerations about study design, 6. statistical considerations of planning about statistical analysis and describing the statistical analysis. We expect researchers will be able to obtain a more reliable conclusion by preparing a study protocol taking our suggestions into consideration.

摘要

相似文献

1
[Statistical considerations for preparation of a study protocol in pharmacological studies].
Nihon Yakurigaku Zasshi. 2000 Jul;116(1):18-22. doi: 10.1254/fpj.116.18.
2
[Statistical considerations for preparation of a study report on pharmacological studies].[关于药理学研究报告撰写的统计学考量]
Nihon Yakurigaku Zasshi. 2000 Jul;116(1):23-8. doi: 10.1254/fpj.116.23.
3
Considerations in adapting clinical trial design.调整临床试验设计时的注意事项。
J Formos Med Assoc. 2008 Dec;107(12 Suppl):14-8. doi: 10.1016/s0929-6646(09)60004-8.
4
Statistics for diagnostic procedures. III. Philosophic and research design considerations.
AJR Am J Roentgenol. 1983 Aug;141(2):409-11. doi: 10.2214/ajr.141.2.409.
5
[Statistical insight to improve reliability of pharmacological studies].[提高药理学研究可靠性的统计学见解]
Nihon Yakurigaku Zasshi. 2000 Jul;116(1):12-7. doi: 10.1254/fpj.116.12.
6
[The role of biostatistics in pharmacological studies (randomization and statistical evaluation)].
Nihon Yakurigaku Zasshi. 2000 Jul;116(1):4-11. doi: 10.1254/fpj.116.4.
7
Research fundamentals: statistical considerations in research design: a simple person's approach.研究基础:研究设计中的统计学考量:一种通俗易懂的方法。
Acad Emerg Med. 2000 Feb;7(2):194-9. doi: 10.1111/j.1553-2712.2000.tb00529.x.
8
A statistics primer.统计学基础。
J Small Anim Pract. 2011 Sep;52(9):456-8. doi: 10.1111/j.1748-5827.2011.01108.x.
9
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.急性缺血性脑卒中动脉内脑溶栓的试验设计与报告标准。
Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17.
10
Objective and perspective determine the choice of composite endpoint.
J Clin Epidemiol. 2008 Feb;61(2):99-101. doi: 10.1016/j.jclinepi.2007.10.001.